13 earlier Form 4 trades (code P or S) here by this insider (13 buys), the last on Dec 9, 2025.
+2.2% median (+2.2% mean) 90-day return after 2 previous buys.
The trade is 38.6% of the 5,700 shares held after it.
No other insider bought within 30 days.
33 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Sullivan Maura Ellen bought about $40.7K of ECBK on Feb 9, 2026, the largest insider purchase at the company since 2024; 33 funds added in the latest 13F quarter.
205 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM ECBK
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$152.0K
Mar 2026
$155.0K
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
$154.0K
Mar 2025
$140.0K
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM ECBK
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$22.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM ECBK
FY Dec 2025
$9.0M
FY Dec 2024
$6.2M
FY Dec 2023
$6.1M
FY Dec 2022
$7.6M
FY Dec 2021
$6.3M
Jun 2026
$11.8M
Mar 2026
$2.8M
Dec 2025
$3.9M
Sep 2025
$4.0M
Jun 2025
$1.8M
Mar 2025
-$649.0K
Dec 2024
$4.4M
Sep 2024
$861.0K
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity ECBK
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt ECBK
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+6.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ECBK
FY Dec 2025
+4.6%
FY Dec 2024
+2.4%
FY Dec 2023
+2.7%
FY Dec 2022
+2.3%
FY Dec 2021
+5.4%
Jun 2026
+6.6%
Mar 2026
+5.6%
Dec 2025
+4.6%
Sep 2025
+3.9%
Jun 2025
+3.2%
Mar 2025
+2.8%
Dec 2024
+2.4%
Sep 2024
+2.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ECBK
FY Dec 2025
+0.5%
FY Dec 2024
+0.3%
FY Dec 2023
+0.4%
FY Dec 2022
+0.3%
FY Dec 2021
+0.6%
Jun 2026
+0.7%
Mar 2026
+0.6%
Dec 2025
+0.5%
Sep 2025
+0.5%
Jun 2025
+0.4%
Mar 2025
+0.3%
Dec 2024
+0.3%
Sep 2024
+0.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital ECBK
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed ECBK
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
15.34x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing ECBK
FY Dec 2025
18.50x
FY Dec 2024
30.92x
FY Dec 2023
23.70x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
14.55x
Mar 2026
14.42x
Dec 2025
18.50x
Sep 2025
19.84x
Jun 2025
23.75x
Mar 2025
26.58x
Dec 2024
30.92x
Sep 2024
36.72x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value ECBK
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+12.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield ECBK
FY Dec 2025
+5.9%
FY Dec 2024
+4.6%
FY Dec 2023
+5.2%
FY Dec 2022
+5.1%
FY Dec 2021
n/a
Jun 2026
+12.7%
Mar 2026
+8.5%
Dec 2025
+5.9%
Sep 2025
+6.8%
Jun 2025
+4.6%
Mar 2025
+4.3%
Dec 2024
+4.6%
Sep 2024
+3.3%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.14x
P/E over trailing EPS growth of 112%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing ECBK
FY Dec 2025
0.19x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.13x
Mar 2026
0.14x
Dec 2025
0.19x
Sep 2025
0.19x
Jun 2025
0.41x
Mar 2025
1.63x
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
ECBK ranks highest on risk and compliance (69th percentile) and growth (37th), and lowest on institutional and government (13th), among Banks peers.
Profitability
22
Inputs
Return on equity+6.6% · 22 pct, sector of 327
Return on assets+0.7% · 22 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Growth
37
Inputs
Revenue growth, YoY+3.6% · 37 pct, sector of 151
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
13
Inputs
Funds adding, latest quarter33 · 13 pct, sector of 257
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
69
Inputs
Short interest, % of float+1.4% · 69 pct, sector of 374
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Financial health, Insider conviction, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.